Over the past 15 years, drugs targeting the incretin hormones (Milestone 9), including glucagon-like peptide 1 (GLP1), have emerged as effective anti-hyperglycaemic agents. GLP1 is produced in the ...
Updates to NICE type 2 diabetes treatment recommendations and how nurses in primary care can implement the changes safely and ...
Bengaluru: A 60-year-old woman with poorly controlled diabetes was started on a glucagon-like peptide (GLP)-1 drug to improve ...